Mount Sinai Hospital

Mount Sinai Hospital was paid $278.96M by Medicaid between Jan 2018 and Dec 2024, across 933 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 8.7% of everything it billed.

33Billing provider infoMOUNT SINAI HOSPITAL
NEW YORK, NY 10029

33aNPI1932103413assigned 06/13/2005

33bProvider typeAmbulance

28Total paid$278.96M

24GClaims5,011,660

24DCodes billed933

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Ambulance providers in New York

Rank by total paid#1 of 219

Median peer was paid$322K

This provider vs. median866×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	48,581	$2.06M
2019	369,807	$16.99M
2020	799,944	$44.79M
2021	1,060,420	$58.85M
2022	1,050,782	$58.79M
2023	970,967	$56.66M
2024incomplete	711,159	$40.82M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	8.7%	224,175	189,406	$24.19M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	8.5%	221,364	192,009	$23.73M
J2350	Injection, ocrelizumab, 1 mg	5.0%	483	458	$13.88M
J9271	Injection, pembrolizumab, 1 mg	4.4%	1,391	1,126	$12.31M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	4.2%	3,608	3,253	$11.72M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.9%	50,569	47,716	$8.21M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	2.7%	53,588	46,984	$7.45M
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	2.2%	1,512	1,016	$6.27M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.2%	38,827	36,161	$6.03M
J9299	Injection, nivolumab, 1 mg	2.2%	678	504	$6.02M
36415	Collection of venous blood by venipuncture	2.0%	495,218	234,324	$5.66M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	1.9%	32,899	31,347	$5.31M

921 more codes

G0378	Hospital observation service, per hour	1.9%	4,707	$5.23M
J3380	Injection, vedolizumab, intravenous, 1 mg	1.8%	1,020	$4.93M
90834	Psychotherapy session, about 45 minutes	1.7%	32,537	$4.61M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.5%	49,769	$4.28M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	1.4%	2,431	$4.02M
J2323	Injection, natalizumab, 1 mg	1.3%	710	$3.61M
93458		1.3%	2,363	$3.57M
96415		1.3%	9,952	$3.56M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.2%	22,649	$3.33M
J2505	Injection, pegfilgrastim, 6 mg	1.1%	815	$2.99M
90832	Psychotherapy session, about 30 minutes	1.0%	23,669	$2.86M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	49,089	$2.57M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	11,356	$2.04M
80053	Comprehensive metabolic panel	<1%	132,109	$1.82M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	18,409	$1.72M
96361	Intravenous infusion, hydration; each additional hour	<1%	15,521	$1.72M
99204	Doctor's office visit, new patient (more involved)	<1%	11,735	$1.72M
J1930	Injection, lanreotide, 1 mg	<1%	331	$1.53M
87536		<1%	18,465	$1.48M
J0485	Injection, belatacept, 1 mg	<1%	1,877	$1.46M
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	852	$1.43M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	8,342	$1.39M
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	38,517	$1.36M
36475		<1%	1,732	$1.35M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	54,144	$1.35M
99203	Doctor's office visit, new patient (routine)	<1%	10,427	$1.28M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	13,735	$1.26M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	14,066	$1.20M
90945		<1%	21,946	$1.16M
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	564	$1.16M
90836		<1%	10,380	$1.09M
J3357	Ustekinumab, for subcutaneous injection, 1 mg	<1%	77	$1.08M
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	<1%	21,759	$1.08M
J2501	Injection, paricalcitol, 1 mcg	<1%	34,218	$1.02M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	5,762	$947K
99205	Prolong outpt/office vis	<1%	5,663	$937K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,683	$912K
93975		<1%	4,221	$901K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	1,454	$889K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	53,207	$876K
J9145	Injection, daratumumab, 10 mg	<1%	332	$872K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	11,088	$861K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	2,390	$845K
86900		<1%	40,181	$831K
81025		<1%	52,455	$779K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	7,152	$779K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,194	$760K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	612	$755K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	15,801	$717K
46607		<1%	916	$716K
J0897	Injection, denosumab, 1 mg	<1%	485	$699K
80061	Lipid panel	<1%	51,753	$687K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	2,716	$686K
77336		<1%	2,257	$655K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	8,886	$631K
96375	Therapeutic injection; each additional sequential IV push	<1%	24,606	$624K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	5,456	$604K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	30,025	$602K
86901		<1%	40,044	$590K
C1874	Stent, coated/covered, with delivery system	<1%	961	$586K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	5,409	$576K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	37,684	$569K
93970		<1%	3,804	$565K
70450	Computed tomography, head or brain; without contrast material	<1%	5,256	$559K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,660	$558K
90792	Psychiatric diagnostic evaluation with medical services	<1%	2,708	$558K
H0035	Mental health partial hospitalization, treatment, less than 24 hours	<1%	2,372	$551K
86480		<1%	10,288	$540K
J9312	Injection, rituximab, 10 mg	<1%	93	$527K
36430		<1%	3,190	$520K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	870	$515K
90677		<1%	3,557	$505K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	18,068	$498K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	13,551	$495K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	6,023	$495K
80048	Basic metabolic panel (calcium, ionized)	<1%	49,051	$488K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	4,472	$487K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	8,118	$486K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	7,159	$484K
54161		<1%	483	$466K
J2357	Injection, omalizumab, 5 mg	<1%	244	$462K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	319	$439K
86850		<1%	39,848	$432K
86361		<1%	13,737	$430K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	35,143	$426K
88185		<1%	2,721	$408K
77386		<1%	1,623	$394K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	258	$390K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	5,880	$390K
90651		<1%	5,128	$382K
90686		<1%	31,606	$381K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	6,258	$373K
J0791	Injection, crizanlizumab-tmca, 5 mg	<1%	100	$372K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	2,886	$371K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	52,285	$367K
93017		<1%	4,880	$363K
96367		<1%	5,704	$363K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	2,206	$362K
59025	Fetal non-stress test	<1%	3,373	$345K
J9999	Not otherwise classified, antineoplastic drugs	<1%	40	$342K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	3,131	$321K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	3,590	$318K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	3,721	$308K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	26,326	$307K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	86	$302K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	9,960	$300K
80050	General health panel	<1%	12,366	$295K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	4,755	$294K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	1,235	$292K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	20,748	$287K
C9062	Injection, daratumumab 10 mg and hyaluronidase-fihj	<1%	63	$285K
J9022	Injection, atezolizumab, 10 mg	<1%	30	$282K
38222		<1%	1,010	$279K
83880		<1%	15,894	$277K
49082		<1%	546	$273K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	27,105	$269K
97162		<1%	2,669	$265K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,157	$264K
G0008	Administration of influenza virus vaccine	<1%	13,195	$263K
90791	Psychiatric diagnostic evaluation	<1%	1,287	$260K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	3,557	$260K
82040		<1%	44,880	$259K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	2,375	$251K
77412		<1%	806	$249K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	3,484	$245K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	12,908	$243K
92134		<1%	4,141	$240K
C1760	Closure device, vascular (implantable/insertable)	<1%	2,423	$239K
88307		<1%	2,133	$235K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	3,986	$235K
87631		<1%	6,576	$233K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	150,745	$231K
76641		<1%	4,028	$227K
49083		<1%	388	$221K
95819		<1%	688	$220K
77063	Screening digital breast tomosynthesis, bilateral	<1%	10,457	$216K
99385		<1%	1,869	$212K
99381		<1%	2,762	$211K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	466	$207K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,412	$206K
C1888	Catheter, ablation, non-cardiac, endovascular (implantable)	<1%	1,926	$199K
75574		<1%	1,284	$199K
J1453	Injection, fosaprepitant, 1 mg	<1%	2,496	$194K
C1769	Guide wire	<1%	5,672	$192K
90715		<1%	8,482	$190K
76819	Fetal biophysical profile; without non-stress testing	<1%	3,970	$189K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	242	$188K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,466	$185K
90671		<1%	1,102	$184K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	713	$183K
T2022	Case management, per month	<1%	1,596	$181K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	268	$180K
99443		<1%	2,969	$178K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,689	$178K
93976		<1%	933	$175K
96401		<1%	3,698	$175K
93971		<1%	3,496	$174K
88341		<1%	2,114	$171K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	6,432	$171K
77300		<1%	589	$169K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	8,422	$168K
76770		<1%	1,209	$168K
88342		<1%	5,096	$166K
94375		<1%	2,310	$165K
19083		<1%	154	$165K
96417		<1%	3,776	$162K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	1,399	$161K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,595	$159K
93356		<1%	1,381	$159K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	1,088	$158K
97802		<1%	3,300	$158K
87522	Neg quan hep c or qual rna	<1%	5,051	$156K
77334		<1%	679	$155K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,021	$154K
77066	Tomosynthesis, mammo	<1%	1,628	$153K
90670		<1%	8,519	$152K
0002A		<1%	3,997	$149K
11900		<1%	994	$143K
82728		<1%	19,065	$140K
17380		<1%	495	$139K
96416		<1%	432	$139K
99386		<1%	1,247	$138K
82784		<1%	17,121	$138K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	227	$137K
J9173	Injection, durvalumab, 10 mg	<1%	14	$137K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,570	$136K
83036	Hemoglobin; glycosylated (A1C)	<1%	52,627	$136K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	3,463	$134K
J9070	Cyclophosphamide, 100 mg	<1%	529	$132K
36000		<1%	11,250	$129K
86769		<1%	4,354	$128K
77065	Tomosynthesis, mammo	<1%	1,913	$127K
99442		<1%	3,158	$127K
0001A		<1%	3,494	$125K
88112		<1%	2,896	$124K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,485	$123K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	3,134	$123K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	2,414	$122K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	51,052	$121K
90837	Psychotherapy session, about an hour	<1%	653	$120K
90750		<1%	1,034	$120K
80069		<1%	9,026	$118K
83655		<1%	9,709	$117K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,121	$116K
43235		<1%	179	$116K
31575		<1%	524	$116K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,340	$114K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	748	$111K
96376		<1%	5,458	$111K
93320		<1%	1,074	$110K
76937		<1%	1,371	$109K
91200		<1%	3,054	$107K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	3,849	$106K
87507		<1%	895	$105K
76642		<1%	2,207	$105K
94060		<1%	928	$104K
86803		<1%	23,259	$104K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	2,569	$102K
87799		<1%	2,702	$102K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	19,711	$102K
17110		<1%	512	$101K
93880		<1%	682	$101K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	7,735	$100K
52000		<1%	176	$100K
87497		<1%	3,471	$99K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,260	$98K
92083		<1%	2,299	$98K
90674		<1%	3,829	$98K
97165		<1%	1,065	$97K
99384		<1%	666	$97K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,253	$97K
90732		<1%	1,633	$96K
90746		<1%	2,167	$95K
83615		<1%	32,725	$95K
87517		<1%	2,728	$93K
80076		<1%	9,000	$93K
76801		<1%	1,525	$93K
76813		<1%	1,495	$92K
83021		<1%	5,505	$92K
88275		<1%	685	$91K
88271		<1%	735	$91K
97803		<1%	2,169	$90K
96402		<1%	2,311	$90K
76536		<1%	1,196	$90K
87428		<1%	4,722	$89K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	5,739	$89K
83883		<1%	10,960	$86K
91320		<1%	1,159	$86K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	2,439	$85K
92060		<1%	1,796	$84K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	1,316	$82K
85610		<1%	38,158	$82K
83735		<1%	32,000	$81K
C1889	Implantable/insertable device, not otherwise classified	<1%	1,919	$81K
96411		<1%	1,568	$80K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	2,073	$79K
83970		<1%	2,521	$79K
82248		<1%	45,362	$78K
11721		<1%	2,415	$78K
93225		<1%	1,191	$78K
82607		<1%	10,609	$77K
58100		<1%	341	$75K
J0583	Injection, bivalirudin, 1 mg	<1%	832	$75K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	6,418	$75K
90734		<1%	3,868	$74K
84443	Thyroid stimulating hormone (TSH)	<1%	22,562	$73K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	3,795	$73K
G0009	Administration of pneumococcal vaccine	<1%	3,388	$72K
36591		<1%	1,996	$72K
J3490	Unclassified drugs	<1%	2,637	$72K
99402		<1%	1,495	$72K
86706		<1%	15,009	$71K
92250		<1%	1,818	$69K
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	<1%	2,165	$67K
90739		<1%	816	$65K
57454		<1%	220	$65K
82670		<1%	3,702	$64K
84403		<1%	4,711	$64K
86923		<1%	4,165	$61K
97116		<1%	1,854	$61K
71046	Radiologic examination, chest; 2 views	<1%	17,545	$61K
94729		<1%	1,586	$61K
99051		<1%	6,445	$60K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	653	$60K
92133		<1%	1,818	$59K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	4,011	$59K
86780		<1%	24,579	$58K
82977		<1%	35,186	$57K
88184		<1%	2,171	$57K
41899	Unlisted procedure, dentoalveolar structures	<1%	46	$56K
70496		<1%	629	$56K
84100		<1%	22,786	$55K
99441		<1%	3,180	$55K
J2796	Injection, romiplostim, 10 micrograms	<1%	26	$55K
93925		<1%	380	$55K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	404	$55K
59430		<1%	292	$54K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	137	$53K
86334		<1%	4,743	$52K
0124A		<1%	1,470	$51K
10060		<1%	298	$51K
81002		<1%	46,154	$51K
90716		<1%	2,815	$51K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	84	$50K
87340		<1%	18,690	$50K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	66	$50K
82570		<1%	17,237	$50K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	4,039	$50K
84550		<1%	19,715	$48K
88237		<1%	593	$48K
90620		<1%	1,088	$48K
83540		<1%	17,751	$48K
77301		<1%	90	$48K
92567		<1%	1,361	$47K
94726		<1%	742	$47K
83550		<1%	17,224	$47K
11102		<1%	119	$46K
86003		<1%	2,648	$46K
0224U		<1%	1,201	$46K
76830	Ultrasound, transvaginal	<1%	2,073	$45K
92557		<1%	1,112	$45K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	221	$45K
95700		<1%	285	$44K
92015	Determination of refractive state	<1%	1,637	$44K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,910	$43K
G0010	Administration of hepatitis b vaccine	<1%	2,398	$43K
84439		<1%	9,785	$43K
90461		<1%	2,246	$43K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,651	$43K
90707		<1%	2,974	$42K
J7304	Contraceptive supply, hormone containing patch, each	<1%	321	$42K
85027		<1%	27,246	$42K
83520		<1%	4,437	$42K
85730		<1%	26,109	$41K
58300		<1%	404	$40K
88304		<1%	2,822	$40K
90694		<1%	1,827	$40K
87086	Culture, bacterial; quantitative colony count, urine	<1%	19,089	$40K
0004A		<1%	1,070	$40K
12001		<1%	190	$39K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	58	$38K
82378		<1%	3,715	$37K
83001		<1%	2,730	$37K
93308		<1%	294	$37K
90472	Immunization administration, each additional vaccine (list separately)	<1%	3,069	$37K
99401		<1%	915	$37K
76942		<1%	368	$37K
S4993	Contraceptive pills for birth control	<1%	4,690	$37K
86360		<1%	1,259	$37K
86704		<1%	8,455	$36K
93226		<1%	626	$36K
82107		<1%	856	$35K
90680		<1%	6,855	$35K
90480		<1%	1,186	$35K
99417	Prolong home eval add 15m	<1%	1,331	$35K
88313		<1%	2,667	$35K
83002		<1%	2,565	$35K
92579		<1%	615	$34K
82043		<1%	11,880	$34K
84270		<1%	2,909	$34K
84460		<1%	14,653	$33K
82150		<1%	8,879	$33K
86762		<1%	3,978	$33K
86765		<1%	4,081	$33K
90678		<1%	167	$33K
T1013	Sign language or oral interpretive services, per 15 minutes	<1%	2,147	$33K
84702		<1%	11,901	$32K
92550		<1%	631	$31K
86870		<1%	1,307	$29K
86922		<1%	1,625	$29K
86140		<1%	14,755	$28K
95708		<1%	105	$28K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	212	$28K
93242		<1%	470	$27K
93325		<1%	927	$27K
95800		<1%	307	$27K
84146		<1%	1,976	$27K
64615		<1%	37	$27K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	29	$26K
84165		<1%	6,631	$26K
82803		<1%	4,132	$26K
86141		<1%	4,096	$26K
97542		<1%	434	$26K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	7,090	$26K
C9399	Unclassified drugs or biologicals	<1%	16	$25K
81001		<1%	25,492	$25K
90648		<1%	4,795	$24K
73562		<1%	2,350	$24K
90698		<1%	4,908	$24K
90633		<1%	4,683	$24K
81206		<1%	194	$24K
80197		<1%	4,191	$23K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	783	$23K
73630		<1%	3,142	$23K
87070		<1%	5,959	$23K
96409		<1%	288	$23K
87480		<1%	2,257	$23K
92551		<1%	538	$23K
99383		<1%	245	$23K
87510		<1%	2,246	$22K
85045		<1%	11,357	$22K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,160	$22K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	1,931	$22K
87660		<1%	2,207	$22K
82533		<1%	2,599	$22K
45190		<1%	13	$22K
80051		<1%	2,179	$22K
96377		<1%	980	$22K
90656		<1%	2,359	$21K
86355		<1%	938	$21K
81003		<1%	21,228	$21K
84075		<1%	10,623	$21K
73610		<1%	2,496	$20K
86787		<1%	3,916	$20K
86300		<1%	1,627	$19K
59841		<1%	25	$19K
0072A		<1%	465	$19K
J9045	Injection, carboplatin, 50 mg	<1%	615	$19K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,430	$19K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	28	$18K
54640		<1%	12	$18K
J1750	Injection, iron dextran, 50 mg	<1%	101	$18K
92202		<1%	607	$18K
77338		<1%	90	$18K
88173		<1%	480	$18K
73130		<1%	2,644	$18K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	342	$18K
73110		<1%	1,996	$17K
85651		<1%	14,808	$17K
84402		<1%	1,066	$17K
0003A		<1%	470	$17K
82105		<1%	4,762	$17K
84156		<1%	7,257	$16K
84484		<1%	24,696	$16K
0071A		<1%	423	$16K
99245		<1%	87	$16K
12011		<1%	118	$16K
86160		<1%	2,334	$16K
86357		<1%	956	$15K
86359		<1%	864	$15K
96127		<1%	2,622	$15K
87077		<1%	5,041	$15K
J9190	Injection, fluorouracil, 500 mg	<1%	705	$15K
J1756	Injection, iron sucrose, 1 mg	<1%	446	$15K
0358T		<1%	505	$15K
96368		<1%	1,173	$15K
73030		<1%	2,147	$15K
88360		<1%	335	$15K
84153		<1%	2,882	$14K
87902		<1%	54	$14K
36465		<1%	47	$14K
74174		<1%	194	$14K
72100		<1%	1,022	$14K
85384		<1%	2,943	$14K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	9,505	$14K
11982		<1%	66	$14K
86592		<1%	13,805	$13K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	10,522	$13K
46601		<1%	38	$13K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	1,728	$13K
84450		<1%	8,820	$13K
90744		<1%	2,894	$13K
90723		<1%	2,918	$13K
82962		<1%	18,512	$12K
70486		<1%	312	$12K
76870		<1%	334	$12K
73560		<1%	1,438	$12K
D0140	Limited oral evaluation - problem focused	<1%	300	$12K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,695	$12K
87186		<1%	5,351	$12K
82565		<1%	9,440	$12K
73502		<1%	1,036	$12K
86376		<1%	1,259	$12K
95012		<1%	955	$11K
82746		<1%	2,050	$11K
97166		<1%	134	$11K
0064A		<1%	274	$11K
82950		<1%	2,914	$11K
82232		<1%	1,335	$11K
86708		<1%	2,478	$11K
83010		<1%	1,672	$11K
93798		<1%	665	$11K
83690		<1%	19,801	$11K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,778	$11K
90662		<1%	714	$11K
92555		<1%	193	$10K
85018		<1%	6,831	$10K
J2704	Injection, propofol, 10 mg	<1%	17,845	$10K
20610		<1%	78	$10K
87640		<1%	553	$10K
82627		<1%	582	$10K
90710		<1%	1,815	$9K
88142		<1%	450	$9K
85378		<1%	3,945	$9K
90661		<1%	288	$9K
86200		<1%	1,107	$9K
86039		<1%	2,686	$9K
86880		<1%	606	$9K
86301		<1%	1,177	$9K
82550		<1%	4,020	$9K
86735		<1%	1,683	$9K
82785		<1%	1,043	$8K
87081		<1%	2,254	$8K
90378		<1%	28	$8K
82247		<1%	11,688	$8K
95249		<1%	146	$8K
0081A		<1%	183	$8K
71045	Radiologic examination, chest; single view	<1%	3,853	$8K
73590		<1%	1,526	$8K
99201		<1%	93	$8K
J8540	Dexamethasone, oral, 0.25 mg	<1%	6,062	$8K
11720		<1%	269	$8K
86800		<1%	884	$7K
0082A		<1%	162	$7K
86235		<1%	1,457	$7K
87641		<1%	424	$7K
0054A		<1%	182	$7K
90700		<1%	1,849	$7K
90632		<1%	154	$7K
90696		<1%	1,792	$7K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	6,105	$7K
87653		<1%	291	$7K
88311		<1%	910	$7K
87210		<1%	3,046	$7K
0154A		<1%	152	$7K
G9012	Other specified case management service not elsewhere classified	<1%	76	$7K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	38	$7K
J9075	Injection, cyclophosphamide, not otherwise specified, 5 mg	<1%	42	$7K
36246		<1%	14	$6K
93750		<1%	168	$6K
Q5101	Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram	<1%	69	$6K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	72	$6K
67028	Intravitreal injection of a pharmacologic agent	<1%	97	$6K
72082		<1%	117	$6K
76775		<1%	133	$6K
80074		<1%	434	$6K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,323	$6K
84305		<1%	360	$6K
82542		<1%	400	$6K
87040		<1%	7,224	$6K
70498		<1%	451	$6K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,389	$6K
86905		<1%	262	$6K
76882		<1%	202	$6K
81267		<1%	47	$6K
C1781	Mesh (implantable)	<1%	98	$5K
C1876	Stent, non-coated/non-covered, with delivery system	<1%	12	$5K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,168	$5K
76857		<1%	263	$5K
88108		<1%	153	$5K
86701		<1%	803	$5K
82677		<1%	408	$5K
93922		<1%	129	$5K
99153	Mod sedat endo service >5yrs	<1%	2,679	$5K
81207		<1%	61	$5K
85245		<1%	356	$5K
D9223	Deep sedation/general anesthesia - each subsequent 15 minute increment	<1%	29	$5K
84425		<1%	579	$5K
92020		<1%	124	$5K
73090		<1%	1,191	$5K
92201		<1%	116	$5K
75716		<1%	78	$5K
84480		<1%	1,303	$5K
81374		<1%	91	$5K
86665		<1%	384	$5K
82397		<1%	659	$5K
88160		<1%	237	$5K
92002		<1%	51	$5K
11981		<1%	27	$5K
86644		<1%	530	$5K
72170		<1%	513	$5K
86431		<1%	1,516	$4K
73070		<1%	764	$4K
S0028	Injection, famotidine, 20 mg	<1%	7,346	$4K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	11,366	$4K
D9222		<1%	29	$4K
88300		<1%	561	$4K
85240		<1%	411	$4K
82310		<1%	3,221	$4K
D0330	Panoramic radiographic image	<1%	134	$4K
58301		<1%	40	$4K
95816		<1%	14	$4K
95886		<1%	53	$4K
86696		<1%	522	$4K
A4648	Tissue marker, implantable, any type, each	<1%	432	$4K
85246		<1%	358	$4K
72131		<1%	106	$4K
J9370	Vincristine sulfate, 1 mg	<1%	402	$4K
83605		<1%	6,963	$4K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,959	$4K
10005		<1%	16	$3K
D0150	Comprehensive oral evaluation - new or established patient	<1%	119	$3K
82024		<1%	105	$3K
92587		<1%	154	$3K
87338		<1%	600	$3K
J1644	Injection, heparin sodium, per 1000 units	<1%	5,704	$3K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	5,949	$3K
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,501	$3K
J9171	Injection, docetaxel, 1 mg	<1%	35	$3K
87205		<1%	4,088	$3K
99152		<1%	3,056	$3K
83519		<1%	343	$3K
88262		<1%	36	$3K
96523		<1%	71	$3K
86225		<1%	919	$3K
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	589	$3K
88720		<1%	1,383	$3K
76514		<1%	98	$3K
84166		<1%	581	$3K
86580		<1%	347	$3K
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	<1%	70	$3K
84163		<1%	277	$3K
73700		<1%	27	$3K
84520		<1%	8,707	$3K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	13,683	$3K
J1380	Injection, estradiol valerate, up to 10 mg	<1%	709	$3K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	17,803	$3K
76820		<1%	131	$3K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,967	$3K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	15	$3K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	106	$3K
82947		<1%	5,781	$3K
84132		<1%	4,753	$3K
86147		<1%	271	$3K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,791	$3K
86255		<1%	900	$3K
86593		<1%	6,787	$3K
84295		<1%	6,432	$3K
76604		<1%	148	$2K
86777		<1%	339	$2K
88172		<1%	62	$2K
D1110	Prophylaxis - adult	<1%	58	$2K
88312		<1%	124	$2K
96380		<1%	111	$2K
92582		<1%	25	$2K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	360	$2K
62270		<1%	14	$2K
82108		<1%	65	$2K
83695		<1%	247	$2K
74018		<1%	477	$2K
82985		<1%	438	$2K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	15	$2K
91318		<1%	39	$2K
97167		<1%	25	$2K
C1753	Catheter, intravascular ultrasound	<1%	26	$2K
A9585	Injection, gadobutrol, 0.1 ml	<1%	545	$2K
82103		<1%	282	$2K
82610		<1%	208	$2K
82553		<1%	1,708	$2K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	13	$2K
99173		<1%	449	$2K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,515	$2K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	24	$2K
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	286	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	14,695	$2K
86336		<1%	423	$2K
J1815	Injection, insulin, per 5 units	<1%	1,558	$2K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,724	$2K
90381		<1%	75	$2K
86304		<1%	182	$2K
97161		<1%	28	$2K
75625		<1%	52	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,303	$2K
0012A		<1%	44	$2K
99421		<1%	24	$2K
89051		<1%	1,890	$2K
92611		<1%	12	$2K
90653		<1%	158	$2K
95957		<1%	14	$2K
82330		<1%	1,668	$2K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,729	$2K
70491		<1%	14	$2K
1036F		<1%	39,793	$2K
84481		<1%	293	$2K
86707		<1%	319	$1K
82435		<1%	5,982	$1K
51701		<1%	13	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,267	$1K
77062		<1%	12	$1K
77061		<1%	12	$1K
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	38	$1K
91321		<1%	37	$1K
84445		<1%	30	$1K
90474		<1%	111	$1K
73060		<1%	259	$1K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	153	$1K
87350		<1%	298	$1K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	58	$1K
97163		<1%	13	$1K
82374		<1%	3,993	$1K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,592	$1K
85597		<1%	79	$1K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	15	$1K
76885		<1%	13	$1K
71250		<1%	16	$1K
73140		<1%	203	$1K
73600		<1%	140	$1K
90611		<1%	201	$1K
91319		<1%	15	$1K
85347		<1%	1,852	$1K
73552		<1%	177	$1K
10061		<1%	12	$1K
87652		<1%	66	$1K
99397		<1%	12	$1K
93799		<1%	490	$1K
84681		<1%	68	$994.72
84155		<1%	4,757	$983.12
D1120	Dental cleaning, child	<1%	28	$981.08
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	2,805	$957.31
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	379	$954.27
85670		<1%	263	$948.81
D0274	Bitewings - four radiographic images	<1%	40	$940.68
87899		<1%	237	$930.25
99382		<1%	12	$928.76
88302		<1%	111	$924.18
OP250		<1%	471	$919.54
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	330	$900.39
83921		<1%	78	$897.22
0011A		<1%	21	$881.80
92025		<1%	14	$828.35
J3480	Injection, potassium chloride, per 2 meq	<1%	799	$817.91
83498		<1%	40	$815.10
J9206	Injection, irinotecan, 20 mg	<1%	43	$771.92
80177		<1%	224	$735.95
86038		<1%	279	$735.89
95885		<1%	12	$718.26
82960		<1%	401	$712.28
83051		<1%	297	$704.62
86356		<1%	90	$701.33
84466		<1%	95	$692.33
82390		<1%	140	$674.52
91308		<1%	401	$665.67
69210		<1%	12	$646.99
90380		<1%	51	$641.48
C1819	Surgical tissue localization and excision device (implantable)	<1%	41	$635.36
0052A		<1%	15	$634.46
84145		<1%	360	$622.97
99188		<1%	106	$615.77
80145		<1%	63	$614.05
D0120	Dental checkup, returning patient	<1%	18	$600.33
86705		<1%	150	$595.19
76818		<1%	15	$587.44
76812		<1%	13	$586.87
J9267	Injection, paclitaxel, 1 mg	<1%	34	$581.92
D9430		<1%	33	$557.60
86828		<1%	13	$554.28
87535		<1%	30	$552.49
73080		<1%	51	$545.89
72110		<1%	25	$544.07
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,660	$539.66
84154		<1%	121	$520.30
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	24	$510.89
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,890	$508.12
93351		<1%	14	$503.45
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	28	$501.06
83525		<1%	49	$491.49
90682		<1%	22	$478.49
11056		<1%	12	$474.41
86778		<1%	57	$471.07
87102		<1%	198	$464.19
51702		<1%	15	$458.94
83516		<1%	20	$458.50
86688		<1%	67	$454.72
85613		<1%	85	$451.51
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	7,117	$438.50
86146		<1%	50	$438.08
82172		<1%	40	$427.31
99406		<1%	12	$399.12
73564		<1%	12	$397.69
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	12	$396.12
86645		<1%	78	$383.07
87206		<1%	357	$382.30
86695		<1%	56	$381.67
76810		<1%	33	$381.12
J0780	Injection, prochlorperazine, up to 10 mg	<1%	268	$372.00
82810		<1%	293	$365.29
D0220	Intraoral - periapical first radiographic image	<1%	43	$362.24
94010		<1%	13	$357.28
82955		<1%	67	$347.05
80164		<1%	93	$342.70
99415	Prolong outpt/office vis	<1%	88	$338.24
80321		<1%	81	$330.75
87324		<1%	105	$328.97
87075		<1%	179	$301.92
4004F		<1%	11,378	$290.98
86687		<1%	67	$286.16
92136		<1%	12	$271.76
90647		<1%	55	$268.29
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	904	$264.39
84260		<1%	14	$264.15
91312		<1%	1,166	$256.99
81268		<1%	48	$250.36
A0425	Ground mileage, per statute mile	<1%	31	$243.89
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	5,630	$236.39
80195		<1%	39	$230.19
84157		<1%	140	$227.96
86709		<1%	54	$227.77
J7509	Methylprednisolone oral, per 4 mg	<1%	88	$221.75
76814		<1%	17	$209.89
99408		<1%	14	$209.70
87116		<1%	133	$209.47
82085		<1%	30	$203.40
84300		<1%	203	$199.94
82575		<1%	68	$195.02
90713		<1%	12	$194.02
84207		<1%	12	$191.00
87449		<1%	228	$185.52
90685		<1%	24	$177.11
J0153	Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)	<1%	15	$164.56
86328		<1%	24	$162.95
72070		<1%	17	$158.96
76512		<1%	14	$156.45
86682		<1%	26	$156.17
82951		<1%	25	$150.48
87220		<1%	126	$147.73
82945		<1%	87	$137.55
D0230	Intraoral - periapical each additional radiographic image	<1%	26	$133.72
C1729	Catheter, drainage	<1%	28	$131.87
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	108	$131.84
85520		<1%	16	$129.28
J1940	Injection, furosemide, up to 20 mg	<1%	639	$127.88
J1245	Injection, dipyridamole, per 10 mg	<1%	24	$127.86
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	309	$126.80
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	155	$120.69
84134		<1%	25	$118.24
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	6,126	$118.23
S0030	Injection, metronidazole, 500 mg	<1%	389	$117.30
71100		<1%	98	$112.57
85014		<1%	651	$112.25
84311		<1%	195	$103.93
J9250	Methotrexate sodium, 5 mg	<1%	72	$103.57
80143		<1%	162	$102.89
J0461	Injection, atropine sulfate, 0.01 mg	<1%	35	$90.42
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	165	$90.24
82952		<1%	104	$88.11
J2060	Injection, lorazepam, 2 mg	<1%	606	$86.16
J1630	Injection, haloperidol, up to 5 mg	<1%	858	$84.91
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	167	$83.78
D9310		<1%	13	$83.59
74019		<1%	12	$82.20
80179		<1%	134	$82.05
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	2,508	$81.50
J2550	Injection, promethazine hcl, up to 50 mg	<1%	195	$81.11
H0049	Alcohol and/or drug screening	<1%	15	$72.72
73620		<1%	28	$61.99
81257		<1%	15	$61.36
83993		<1%	14	$56.40
84133		<1%	38	$56.19
J0280	Injection, aminophyllin, up to 250 mg	<1%	12	$53.08
87430		<1%	13	$52.00
J1650	Injection, enoxaparin sodium, 10 mg	<1%	155	$51.52
91307		<1%	860	$51.14
S0077	Injection, clindamycin phosphate, 300 mg	<1%	26	$51.02
83050		<1%	62	$50.57
80320		<1%	377	$47.54
87254		<1%	12	$47.32
82375		<1%	39	$42.63
82465		<1%	12	$35.21
84436		<1%	12	$34.20
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	13	$28.70
J1171	Injection, hydromorphone, 0.1 mg	<1%	19	$28.17
84478		<1%	13	$25.15
83935		<1%	12	$21.39
91305		<1%	183	$20.19
91306		<1%	120	$19.04
82948		<1%	131	$19.00
80329		<1%	134	$17.98
G9902	Patient screened for tobacco use and identified as a tobacco user	<1%	5,710	$16.98
91300		<1%	3,593	$14.01
J1836	Injection, metronidazole, 10 mg	<1%	70	$9.85
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	17	$9.53
82436		<1%	12	$7.43
87176		<1%	21	$6.40
J1598	Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg	<1%	87	$6.14
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	12	$3.11
J7510	Prednisolone oral, per 5 mg	<1%	63	$2.98
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	115	$2.59
91317		<1%	15	$2.00
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	38	$1.98
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	103	$0.64
C9113	Injection, pantoprazole sodium, per vial	<1%	20	$0.57
G9740	Hospice services given to patient any time during the measurement period	<1%	193	$0.46
G9687	Hospice services provided to patient any time during the measurement period	<1%	306	$0.43
G9903	Patient screened for tobacco use and identified as a tobacco non-user	<1%	20	$0.17
3078F		<1%	4,043	$0.11
G9691	Patient had hospice services any time during the measurement period	<1%	24	$0.10
3074F		<1%	3,373	$0.09
3077F		<1%	1,047	$0.08
3080F		<1%	244	$0.04
3079F		<1%	584	$0.02
3044F		<1%	1,206	$0.01
3048F		<1%	1,507	$0.01
3049F		0%	436	$0.00
G8754	Most recent diastolic blood pressure < 90 mmhg	0%	1,546	$0.00
91315		0%	130	$0.00
99429		0%	3,433	$0.00
3075F		0%	467	$0.00
1111F		0%	165	$0.00
G8756	No documentation of blood pressure measurement, reason not given	0%	279	$0.00
G8755	Most recent diastolic blood pressure >= 90 mmhg	0%	129	$0.00
D1310		0%	17	$0.00
1123F		0%	416	$0.00
G9231	Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period	0%	153	$0.00
0503F		0%	17	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	12	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	12	$0.00
G8420	Bmi is documented within normal parameters and no follow-up plan is required	0%	16	$0.00
81599		0%	15	$0.00
91301		0%	12	$0.00
3051F		0%	52	$0.00
99080		0%	10,720	$0.00
G8753	Most recent systolic blood pressure >= 140 mmhg	0%	523	$0.00
G8938	Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible	0%	1,790	$0.00
3050F		0%	484	$0.00
G8752	Most recent systolic blood pressure < 140 mmhg	0%	1,177	$0.00
3046F		0%	53	$0.00
4040F		0%	82	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	13	$0.00
93571		0%	24	$0.00
3725F		0%	12	$0.00
3045F		0%	36	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCANLON, DON (CEO MEDICAL CENTER)

Same official

Other billing entities under SCANLON, DON

Full network →

Provider	Location	Paid
Mount Sinai Hospital	New York, NY	$4.35M
Mount Sinai Hospital	New York, NY	$8K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.